
Loading, please wait...

Loading, please wait...

Clinicians frequently encounter absence seizures in pediatric patients with idiopathic generalized epilepsies. Manual review of prolonged EEG records is often laborious and time-consuming. However, automated absence seizure detection offers a potential solution to improve laboratory workflow and clinical efficiency.
A recent study published in the Journal of Clinical Neurophysiology evaluated the Persyst software's performance in a pediatric cohort. Researchers analyzed eighty-one EEG records from sixty-nine patients to compare different software modules. They specifically focused on the seizure detection module and the spikeburst module, which identifies clusters of interictal epileptiform discharges.
The study results revealed that the seizure detection module achieved a sensitivity of 78%. In contrast, the spikeburst module showed varying results based on the duration settings. Specifically, a 1-second threshold reached a high sensitivity of 95% but resulted in 23 false positives every 24 hours. Increasing the threshold to 3 seconds reduced false positives to zero, yet the sensitivity dropped to 61%.
Consequently, the researchers determined that a 2-second spikeburst threshold represents the most feasible compromise. This setting offers a sensitivity of 77% with only one false positive per day. Moreover, both software modules performed exceptionally well for longer events, reaching 99% sensitivity for seizures exceeding nine seconds. Most false positives occurred due to interictal discharges rather than actual seizures.
Ultimately, these automated tools assist neurologists in triaging large volumes of EEG data. By using the 2-second spikeburst setting, clinicians can maintain high detection accuracy while minimizing the burden of reviewing false alarms. This efficiency gain is particularly valuable in high-volume pediatric neurology centers where rapid interpretation is essential for treatment adjustments.
The spikeburst module with a 2-second threshold duration is recommended. It provides a balanced performance with 77% sensitivity and a very low false positive rate of one per 24 hours.
The software is highly accurate for longer events. Both the seizure detection and spikeburst modules reach a 99% detection rate for absence seizures lasting more than 9 seconds.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References
Reus EEM et al. Performance of Automated Detection Software in Absence Seizures. J Clin Neurophysiol. 2026 Feb 19. doi: 10.1097/WNP.0000000000001242. PMID: 41712934.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study evaluates Persyst's automated detection software for absence seizures in pediatric EEGs, identifying the 2-second module as the most usable clinical...
5 months ago

Diabetic kidney disease remains a major cause of renal failure despite renin-angiotensin system blockade. Learn how combining SGLT2 inhibitors, nonsteroidal MRAs, GLP-1 receptor agonists, and novel aldosterone synthase or endothelin inhibitors addresses residual cardiorenal risk.
Today

A multicenter MPOG database study of 289,047 cesarean delivery cases analyzed adherence to obstetric anesthesia best practices. General anesthesia avoidance reached 97.0%, while post-spinal vasopressor infusions (55.4%) and hypothermia prevention (56.7%) showed the lowest compliance, highlighting key targets.
Yesterday

A comprehensive meta-analysis shows digital health technologies significantly improve 6-minute walk distance and peak oxygen uptake in chronic heart failure patients, highlighting the clinical promise of structured remote cardiac rehabilitation.
Today

Recent research assesses an automated pipeline for CT-based vertebral finite element analysis, revealing how boundary condition components—especially load-point assignment—impact fracture-load accuracy in spinal biomechanics.
Today

A comprehensive analysis of continuous glucose monitoring systems under European Medical Device Regulation 2017/745, examining conformity assessment challenges, Notified Body backlogs, EUDAMED rollout delays, and the critical need for transparent post-market surveillance.
Today